Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers
NCT02557061Completed
- Sponsor
- Rouen University Hospital
- Start
- Apr 2009
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Rouen University Hospital. Primary endpoints: Number of patients with tumor infiltrate by T-lymphocytes (CD3+) at Day 1 and Overall Survival at 2 years. Started Apr 2009; status: completed.
Beyond the preview
Go deeper on NCT02557061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02557061.